Cited by 1,273CRISPR and Genetic EngineeringRNA regulation and diseaseRNA Interference and Gene Delivery

The DOI matches its Crossref record; 81 of the 82 references it cites were found in a registry or an index.

Off-target Effects in CRISPR/Cas9-mediated Genome Engineering

Open access

Zhang, Xiao-Hui, Tee, Louis Y, Wang, Xiao-Gang, Huang, Qun-Shan, Yang, Shi-Hua·2015·Molecular Therapy - Nucleic Acids

DOI 10.1038/mtna.2015.37PMC PMC4877446

Open this paper in CoChat — free account Open PDF

Abstract

CRISPR/Cas9 is a versatile genome-editing technology that is widely used for studying the functionality of genetic elements, creating genetically modified organisms as well as preclinical research of genetic disorders. However, the high frequency of off-target activity (≥50%)-RGEN (RNA-guided endonuclease)-induced mutations at sites other than the intended on-target site-is one major concern, especially for therapeutic and clinical applications. Here, we review the basic mechanisms underlying off-target cutting in the CRISPR/Cas9 system, methods for detecting off-target mutations, and strategies for minimizing off-target cleavage. The improvement off-target specificity in the CRISPR/Cas9 system will provide solid genotype-phenotype correlations, and thus enable faithful interpretation of genome-editing data, which will certainly facilitate the basic and clinical application of this technology.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1038/mtna.2015.37

Cites

81 of 81 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity
Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J. A., & Charpentier, E. (2012) · Science · doi:10.1126/science.1225829 · Cited by 17,116
Multiplex Genome Engineering Using CRISPR/Cas Systems
Cong, L., Ran, F. A., Cox, D., Lin, S., Barretto, R., Habib, N., Hsu, P. D., Wu, X., Jiang, W., Marraffini, L. A., et al. (2013) · Science · doi:10.1126/science.1231143 · Cited by 15,339
Genome engineering using the CRISPR-Cas9 system
Ran, F. A., Hsu, P. D., Wright, J., Agarwala, V., Scott, D. A., & Zhang, F. (2013) · Nature Protocols · doi:10.1038/nprot.2013.143 · Cited by 11,133
RNA-Guided Human Genome Engineering via Cas9
Mali, P., Yang, L., Esvelt, K. M., Aach, J., Guell, M., DiCarlo, J. E., Norville, J. E., & Church, G. M. (2013) · Science · doi:10.1126/science.1232033 · Cited by 9,210
The new frontier of genome engineering with CRISPR-Cas9
Doudna, J. A., & Charpentier, E. (2014) · Science · doi:10.1126/science.1258096 · Cited by 7,062
Development and Applications of CRISPR-Cas9 for Genome Engineering
Hsu, P. D., Lander, E. S., & Zhang, F. (2014) · Cell · doi:10.1016/j.cell.2014.05.010 · Cited by 5,762
Improved vectors and genome-wide libraries for CRISPR screening
Sanjana, N. E., Shalem, O., & Zhang, F. (2014) · Nature Methods · doi:10.1038/nmeth.3047 · Cited by 5,239
Repurposing CRISPR as an RNA-Guided Platform for Sequence-Specific Control of Gene Expression
Qi, L. S., Larson, M. H., Gilbert, L. A., Doudna, J. A., Weissman, J. S., Arkin, A. P., & Lim, W. A. (2013) · Cell · doi:10.1016/j.cell.2013.02.022 · Cited by 5,016
Cpf1 Is a Single RNA-Guided Endonuclease of a Class 2 CRISPR-Cas System
Zetsche, B., Gootenberg, J. S., Abudayyeh, O. O., Slaymaker, I. M., Makarova, K. S., Essletzbichler, P., Volz, S. E., Joung, J., van der Oost, J., Regev, A., et al. (2015) · Cell · doi:10.1016/j.cell.2015.09.038 · Cited by 4,761
DNA targeting specificity of RNA-guided Cas9 nucleases
Hsu, P. D., Scott, D. A., Weinstein, J. A., Ran, F. A., Konermann, S., Agarwala, V., Li, Y., Fine, E. J., Wu, X., Shalem, O., et al. (2013) · Nature Biotechnology · doi:10.1038/nbt.2647 · Cited by 4,741

Flagged first, then by citations

Show all 82 references

1 of the 82 references couldn’t be matched to a known paper.

Sorted by citations

CRISPR technology: A decade of genome editing is only the beginning
Wang, J. Y., & Doudna, J. A. (2023) · Science · doi:10.1126/science.add8643 · Cited by 1,105
DNA-Free Genetically Edited Grapevine and Apple Protoplast Using CRISPR/Cas9 Ribonucleoproteins
Malnoy, M., Viola, R., Jung, M., Koo, O. J., Kim, S., Kim, J., Velasco, R., & Kanchiswamy, C. N. (2016) · Frontiers in Plant Science · doi:10.3389/fpls.2016.01904 · Cited by 766
CRISPR Gene Therapy: Applications, Limitations, and Implications for the Future
Uddin, F. Z., Rudin, C. M., & Sen, T. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.01387 · Cited by 641
Huntington disease: new insights into molecular pathogenesis and therapeutic opportunities
Tabrizi, S. J., Flower, M. D., Ross, C. A., & Wild, E. J. (2020) · Nature Reviews Neurology · doi:10.1038/s41582-020-0389-4 · Cited by 568
CRISPR/Cas system: recent advances and future prospects for genome editing
Manghwar, H., Lindsey, K., Zhang, X., & Jin, S. (2019) · Trends in Plant Science · doi:10.1016/j.tplants.2019.09.006 · Cited by 529
Self-citation
Defining and improving the genome-wide specificities of CRISPR–Cas9 nucleases
Tsai, S. Q., & Joung, J. K. (2016) · Nature Reviews Genetics · doi:10.1038/nrg.2016.28 · Cited by 520
Mechanism and Applications of CRISPR/Cas-9-Mediated Genome Editing
Mengstie, M. A., & Wondimu, B. Z. (2021) · Biologics: Targets and Therapy · doi:10.2147/btt.s326422 · Cited by 478
CRISPR/Cas Systems in Genome Editing: Methodologies and Tools for sgRNA Design, Off‐Target Evaluation, and Strategies to Mitigate Off‐Target Effects
Manghwar, H., Li, B., Ding, X., Hussain, A., Lindsey, K., Zhang, X., & Jin, S. (2020) · Advanced Science · doi:10.1002/advs.201902312 · Cited by 347
Self-citation
Precise plant genome editing using base editors and prime editors
Molla, K. A., Sretenovic, S., Bansal, K. C., & Qi, Y. (2021) · Nature Plants · doi:10.1038/s41477-021-00991-1 · Cited by 387
Optimized CRISPR guide RNA design for two high-fidelity Cas9 variants by deep learning
Wang, D., Zhang, C., Wang, B., Li, B., Wang, Q., Liu, D., Wang, H., Zhou, Y., Shi, L., Lan, F., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-12281-8 · Cited by 331
Immunogenicity of CAR T cells in cancer therapy
Wagner, D. L., Fritsche, E., Pulsipher, M. A., Ahmed, N. M., Hamieh, M., Hegde, M. G., Ruella, M., Savoldo, B., Shah, N. N., Turtle, C. J., et al. (2021) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-021-00476-2 · Cited by 318
Research and therapy with induced pluripotent stem cells (iPSCs): social, legal, and ethical considerations
Moradi, S., Mahdizadeh, H., Šarić, T., Kim, J., Harati, J., Shahsavarani, H., Greber, B., & Moore, J. B. (2019) · Stem Cell Research & Therapy · doi:10.1186/s13287-019-1455-y · Cited by 313
Evolution of Resistance Against CRISPR/Cas9 Gene Drive
Unckless, R. L., Clark, A. G., & Messer, P. W. (2016) · Genetics · doi:10.1534/genetics.116.197285 · Cited by 288
Overcoming challenges and dogmas to understand the functions of pseudogenes
Cheetham, S. W., Faulkner, G. J., & Dinger, M. E. (2019) · Nature Reviews Genetics · doi:10.1038/s41576-019-0196-1 · Cited by 294
Next-generation stem cells — ushering in a new era of cell-based therapies
Kimbrel, E. A., & Lanza, R. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-0064-x · Cited by 295
Immunomodulation—a general review of the current state-of-the-art and new therapeutic strategies for targeting the immune system
Strzelec, M., Detka, J., Mieszczak, P., Sobocińska, M. K., & Majka, M. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1127704 · Cited by 266
Comprehensive review of CRISPR-based gene editing: Mechanisms, challenges, and applications in cancer therapy
Chehelgerdi, M., Chehelgerdi, M., Khorramian-Ghahfarokhi, M., Shafieizadeh, M., Mahmoudi, E., Eskandari, F., Rashidi, M., Arshi, A., & Mokhtari-Farsani, A. (2024) · Molecular Cancer · doi:10.1186/s12943-023-01925-5 · Cited by 251
Genome editing with the CRISPR‐Cas system: an art, ethics and global regulatory perspective
Zhang, D., Hussain, A., Manghwar, H., Xie, K., Xie, S., Zhao, S., Larkin, R. M., Qing, P., Jin, S., & Ding, F. (2020) · Plant Biotechnology Journal · doi:10.1111/pbi.13383 · Cited by 254
Plant Genome Engineering for Targeted Improvement of Crop Traits
Sedeek, K. E. M., Mahas, A., & Mahfouz, M. M. (2019) · Frontiers in Plant Science · doi:10.3389/fpls.2019.00114 · Cited by 237
In vivo delivery of CRISPR-Cas9 therapeutics: Progress and challenges
Behr, M., Zhou, J., Xu, B., & Zhang, H. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.05.020 · Cited by 210
Microbial proteases: ubiquitous enzymes with innumerable uses
Solanki, P., Putatunda, C., Kumar, A., Bhatia, R. K., & Walia, A. (2021) · 3 Biotech · doi:10.1007/s13205-021-02928-z · Cited by 228
Genome-Wide Analysis of Experimentally Evolved Candida auris Reveals Multiple Novel Mechanisms of Multidrug Resistance
Carolus, H., Pierson, S., Muñoz, J. F., Subotić, A., Cruz, R. B., Cuomo, C. A., & Van Dijck, P. (2021) · mBio · doi:10.1128/mbio.03333-20 · Cited by 211
CRISPR-Cas9 ribonucleoprotein-mediated co-editing and counterselection in the rice blast fungus
Foster, A. J., Martín-Urdiroz, M., Xia, Y., Wright, S., Soanes, D. M., & Talbot, N. J. (2018) · Scientific Reports · doi:10.1038/s41598-018-32702-w · Cited by 214
Aedes aegypti Mosquitoes Detect Acidic Volatiles Found in Human Odor Using the IR8a Pathway
Raji, J. I., Melo, N., Castillo, J. S., Gonzalez, S., Saldana, V. A., Stensmyr, M. C., & DeGennaro, M. (2019) · Current Biology · doi:10.1016/j.cub.2019.02.045 · Cited by 204
Computational approaches for effective CRISPR guide RNA design and evaluation
Liu, G., Zhang, Y., & Zhang, T. (2019) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2019.11.006 · Cited by 206
Gene editing and CRISPR in the clinic: current and future perspectives
Hirakawa, M. P., Krishnakumar, R., Timlin, J. A., Carney, J. P., & Butler, K. S. (2020) · Bioscience Reports · doi:10.1042/bsr20200127 · Cited by 207
Mitochondria transfer enhances proliferation, migration, and osteogenic differentiation of bone marrow mesenchymal stem cell and promotes bone defect healing
Guo, Y., Chi, X., Wang, Y., Heng, B. C., Wei, Y. Q., Zhang, X., Zhao, H., Yin, Y., & Deng, X. (2020) · Stem Cell Research & Therapy · doi:10.1186/s13287-020-01704-9 · Cited by 191
Self-citation
Off-target predictions in CRISPR-Cas9 gene editing using deep learning
Lin, J., & Wong, K.-C. (2018) · Bioinformatics · doi:10.1093/bioinformatics/bty554 · Cited by 185
PTEN-opathies: from biological insights to evidence-based precision medicine
Yehia, L., Ngeow, J. Y. Y., & Eng, C. (2019) · Journal of Clinical Investigation · doi:10.1172/jci121277 · Cited by 178
In utero nanoparticle delivery for site-specific genome editing
Ricciardi, A. S., Bahal, R., Farrelly, J. S., Quijano, E., Bianchi, A. H., Luks, V. L., Putman, R., López‐Giráldez, F., Coşkun, S., Song, E., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04894-2 · Cited by 176
Genome-Wide Assessment of Efficiency and Specificity in CRISPR/Cas9 Mediated Multiple Site Targeting in Arabidopsis
Peterson, B. A., Haak, D. C., Nishimura, M. T., Teixeira, P. J. P. L., James, S. R., Dangl, J. L., & Nimchuk, Z. L. (2016) · PLOS ONE · doi:10.1371/journal.pone.0162169 · Cited by 172
CRISPR-Cas9 off-targeting assessment with nucleic acid duplex energy parameters
Alkan, F., Wenzel, A., Anthon, C., Havgaard, J. H., & Gorodkin, J. (2018) · Genome biology · doi:10.1186/s13059-018-1534-x · Cited by 174
In vivo Editing of the Human Mutant Rhodopsin Gene by Electroporation of Plasmid-based CRISPR/Cas9 in the Mouse Retina
Latella, M. C., Salvo, M. T. D., Cocchiarella, F., Benati, D., Grisendi, G., Comitato, A., Marigo, V., & Recchia, A. (2016) · Molecular Therapy — Nucleic Acids · doi:10.1038/mtna.2016.92 · Cited by 168
In vivo genome editing in animals using AAV-CRISPR system: applications to translational research of human disease
Lau, C.-H., & Suh, Y. (2017) · F1000Research · doi:10.12688/f1000research.11243.1 · Cited by 161
In Situ Gene Therapy via AAV-CRISPR-Cas9-Mediated Targeted Gene Regulation
Moreno, A. M., Fu, X., Zhu, J., Katrekar, D., Shih, Y.-R. V., Marlett, J., Cabotaje, J., Tat, J., Naughton, J., Lisowski, L., et al. (2018) · Molecular Therapy · doi:10.1016/j.ymthe.2018.04.017 · Cited by 159
TALENs—an indispensable tool in the era of CRISPR: a mini review
Bhardwaj, A., & Nain, V. (2021) · Journal of Genetic Engineering and Biotechnology · doi:10.1186/s43141-021-00225-z · Cited by 162
Multifunctional nanoparticles for cancer immunotherapy: A groundbreaking approach for reprogramming malfunctioned tumor environment
Sau, S., Alsaab, H. O., Bhise, K., Alzhrani, R. M., Nabil, G., & Iyer, A. K. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.01.028 · Cited by 154
High-fidelity CRISPR/Cas9- based gene-specific hydroxymethylation rescues gene expression and attenuates renal fibrosis
Xu, X., Tan, X., Tampe, B., Wilhelmi, T., Hulshoff, M. S., Saito, S., Moser, T., Kalluri, R., Hasenfuss, G. P., Zeisberg, E. M., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-05766-5 · Cited by 147
A Critical Review: Recent Advancements in the Use of CRISPR/Cas9 Technology to Enhance Crops and Alleviate Global Food Crises
Rasheed, A., Gill, R. A., Hassan, M., Mahmood, A., Qari, S. H., Zaman, Q. U., Ilyas, M., Aamer, M., Batool, M., Li, H., et al. (2021) · Current Issues in Molecular Biology · doi:10.3390/cimb43030135 · Cited by 154
Plant pangenomics: approaches, applications and advancements
Danilevicz, M. F., Fernandez, C. G. T., Marsh, J. I., Bayer, P. E., & Edwards, D. (2020) · Current Opinion in Plant Biology · doi:10.1016/j.pbi.2019.12.005 · Cited by 150
A deep insight into CRISPR/Cas9 application in CAR-T cell-based tumor immunotherapies
Razeghian, E., Nasution, M. K. M., Rahman, H. S., Gardanova, Z. R., Abdelbasset, W. K., Surendar, A., Bokov, D. O., Suksatan, W., Nakhaei, P., Shariatzadeh, S., et al. (2021) · Stem Cell Research & Therapy · doi:10.1186/s13287-021-02510-7 · Cited by 147
Next-generation cell therapies: the emerging role of CAR-NK cells
Başar, R., Daher, M., & Rezvani, K. (2020) · Blood Advances · doi:10.1182/bloodadvances.2020002547 · Cited by 145
CRISPR/Cas9 gene editing: a new approach for overcoming drug resistance in cancer
Vaghari‐Tabari, M., Hassanpour, P., Sadeghsoltani, F., Malakoti, F., Alemi, F., Qujeq, D., Asemi, Z., & Yousefi, B. (2022) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-022-00348-2 · Cited by 137
CRISPR RNA-Dependent Binding and Cleavage of Endogenous RNAs by the Campylobacter jejuni Cas9
Dugar, G., Leenay, R. T., Eisenbart, S. K., Bischler, T., Aul, B. U., Beisel, C. L., & Sharma, C. M. (2018) · Molecular Cell · doi:10.1016/j.molcel.2018.01.032 · Cited by 144
Brain Organoids and the Study of Neurodevelopment
Trujillo, C. A., & Muotri, A. R. (2018) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2018.09.005 · Cited by 138
Genetics, Mechanisms, and Therapeutic Progress in Polyglutamine Spinocerebellar Ataxias
Buijsen, R. A. M., Toonen, L. J. A., Gardiner, S. L., & van Roon‐Mom, W. (2019) · Neurotherapeutics · doi:10.1007/s13311-018-00696-y · Cited by 143
CRISPR/Cas9 systems: Delivery technologies and biomedical applications
Du, Y., Liu, Y., Hu, J., Peng, X., & Liu, Z. (2023) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2023.100854 · Cited by 142
Genome Editing in Cereals: Approaches, Applications and Challenges
Ansari, W. A., Chandanshive, S. U., Bhatt, V. D., Nadaf, A. B., Vats, S., Katara, J. L., Sonah, H., & Deshmukh, R. K. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21114040 · Cited by 137
Plant breeding advancements with “CRISPR-Cas” genome editing technologies will assist future food security
Ahmad, M. (2023) · Frontiers in Plant Science · doi:10.3389/fpls.2023.1133036 · Cited by 135
Computational Tools and Resources for CRISPR/Cas Genome Editing
Li, C., Chu, W., Gill, R. A., Sang, S., Shi, Y., Hu, X., Yang, Y., Zaman, Q. U., & Zhang, B. (2022) · Genomics Proteomics & Bioinformatics · doi:10.1016/j.gpb.2022.02.006 · Cited by 132
CRISPR/Cas9 gene-editing: Research technologies, clinical applications and ethical considerations
Memi, F., Ntokou, A., & Papangeli, I. (2018) · Seminars in Perinatology · doi:10.1053/j.semperi.2018.09.003 · Cited by 134
Versatile detection with CRISPR/Cas system from applications to challenges
Wu, H., Chen, X., Zhang, M., Wang, X., Chen, Y., Qian, C., Wu, J. F., & Xu, J. (2020) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2020.116150 · Cited by 130
Self-citation
Enhancing RNA-lipid nanoparticle delivery: Organ- and cell-specificity and barcoding strategies
Wei, P.-S., Thota, N., John, G., Chang, E., Lee, S., Wang, Y., Ma, Z., Tsai, Y.-H., & Mei, K. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.08.030 · Cited by 138
Advances in the Study of Heart Development and Disease Using Zebrafish
Brown, D., Samsa, L. A., Li, Q., & Liu, J. (2016) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd3020013 · Cited by 139
How chromosomal inversions reorient the evolutionary process
Berdan, E. L., Barton, N., Butlin, R. K., Charlesworth, B., Faria, R., Fragata, I., Gilbert, K. J., Jay, P., Kapun, M., Lotterhos, K. E., et al. (2023) · Journal of Evolutionary Biology · doi:10.1111/jeb.14242 · Cited by 136
Thermozymes: Adaptive strategies and tools for their biotechnological applications
Kumar, S., Dangi, A. K., Shukla, P., Baishya, D., & Khare, S. K. (2019) · Bioresource Technology · doi:10.1016/j.biortech.2019.01.088 · Cited by 125
What is the available evidence for the range of applications of genome-editing as a new tool for plant trait modification and the potential occurrence of associated off-target effects: a systematic map
Modrzejewski, D., Hartung, F., Sprink, T., Krause, D., Kohl, C., & Wilhelm, R. (2019) · Environmental Evidence · doi:10.1186/s13750-019-0171-5 · Cited by 134
Therapeutic gene editing: delivery and regulatory perspectives
Shim, G., Kim, D., Park, G. T., Jin, H., Suh, S., & Oh, Y. (2017) · Acta Pharmacologica Sinica · doi:10.1038/aps.2017.2 · Cited by 125
CRISPR/Cas with ribonucleoprotein complexes and transiently selected telomere vectors allows highly efficient marker-free and multiple genome editing in Botrytis cinerea
Leisen, T., Bietz, F., Werner, J. A., Wegner, A., Schaffrath, U., Scheuring, D., Willmund, F., Mosbach, A., Scalliet, G., & Hahn, M. (2020) · PLoS Pathogens · doi:10.1371/journal.ppat.1008326 · Cited by 121
CRISPR/Cas9-mediated mutagenesis of CAROTENOID CLEAVAGE DIOXYGENASE 8 in tomato provides resistance against the parasitic weed Phelipanche aegyptiaca
Bari, V. K., Nassar, J. A., Kheredin, S. M., Gal‐On, A., Ron, M., Britt, A., Steele, D. B., Yoder, J. I., & Aly, R. (2019) · Scientific Reports · doi:10.1038/s41598-019-47893-z · Cited by 121
Autologous Induced Pluripotent Stem Cell–Based Cell Therapies: Promise, Progress, and Challenges
Madrid, M., Sumen, C., Aivio, S., & Saklayen, N. (2021) · Current Protocols · doi:10.1002/cpz1.88 · Cited by 121
Plant Genome Editing and the Relevance of Off-Target Changes
Graham, N. D., Patil, G., Bubeck, D. M., Dobert, R. C., Glenn, K. C., Gutsche, A. T., Kumar, S., Lindbo, J. A., Maas, L., May, G. D., et al. (2020) · PLANT PHYSIOLOGY · doi:10.1104/pp.19.01194 · Cited by 120
Using traditional machine learning and deep learning methods for on- and off-target prediction in CRISPR/Cas9: a review
Sherkatghanad, Z., Abdar, M., Charlier, J., & Makarenkov, V. (2023) · Briefings in Bioinformatics · doi:10.1093/bib/bbad131 · Cited by 123
Genome-wide determination of on-target and off-target characteristics for RNA-guided DNA methylation by dCas9 methyltransferases
Lin, L., Liu, Y., Xu, F., Huang, J., Daugaard, T. F., Petersen, T. S., Hansen, B. D., Ye, L., Zhou, Q. X., Fang, F., et al. (2018) · GigaScience · doi:10.1093/gigascience/giy011 · Cited by 114
CRISPR–Cas ribonucleoprotein mediated homology-directed repair for efficient targeted genome editing in microalgae Nannochloropsis oceanica IMET1
Naduthodi, M. I. S., Mohanraju, P., Südfeld, C., D’Adamo, S., Barbosa, M. J., & John van der, O. O. S. T. (2019) · Biotechnology for Biofuels · doi:10.1186/s13068-019-1401-3 · Cited by 115
Ex vivo cell-based CRISPR/Cas9 genome editing for therapeutic applications
Li, Y., Glass, Z., Huang, M., Chen, Z., & Xu, Q. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2019.119711 · Cited by 117
Human genetic variation alters CRISPR-Cas9 on- and off-targeting specificity at therapeutically implicated loci
Lessard, S., Francioli, L. C., Alföldi, J., Tardif, J., Ellinor, P. T., MacArthur, D. G., Lettre, G., Orkin, S. H., & Canver, M. C. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1714640114 · Cited by 115
Toward Clinical Implementation of Next-Generation Sequencing-Based Genetic Testing in Rare Diseases: Where Are We?
Liu, Z., Zhu, L., Roberts, R. A., & Tong, W. (2019) · Trends in Genetics · doi:10.1016/j.tig.2019.08.006 · Cited by 116
Dominant optic atrophy: Culprit mitochondria in the optic nerve
Lenaers, G., Neutzner, A., Dantec, Y. L., Jüschke, C., Xiao, T., Decembrini, S., Swirski, S., Kieninger, S., Ağca, C., Kim, U. S., et al. (2020) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2020.100935 · Cited by 113
Engineering the next generation of CAR-NK immunotherapies
Biederstädt, A., & Rezvani, K. (2021) · International Journal of Hematology · doi:10.1007/s12185-021-03209-4 · Cited by 114
Advancements and Obstacles of CRISPR-Cas9 Technology in Translational Research
You, L., Tong, R., Li, M., Liu, Y., Xue, J., & Lü, Y. (2019) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2019.02.008 · Cited by 111
Cas9 interrogates DNA in discrete steps modulated by mismatches and supercoiling
Ivanov, I. E., Wright, A. V., Cofsky, J. C., Aris, K., Doudna, J. A., & Bryant, Z. D. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1913445117 · Cited by 109
CRISPR-Cas9 directed genome engineering for enhancing salt stress tolerance in rice
Farhat, S., Jain, N., Singh, N., Sreevathsa, R., Dash, P. K., Rai, R., Yadav, S., Kumar, P., Sarkar, A. K., Jain, A., et al. (2019) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2019.05.003 · Cited by 108
Revolutionizing cancer treatment: enhancing CAR-T cell therapy with CRISPR/Cas9 gene editing technology
Tao, R., Han, X., Bai, X., Yu, J., Ma, Y.-W., Chen, W., Zhang, D., & Li, Z. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1354825 · Cited by 109
Silence superoxide dismutase 1 (SOD1): a promising therapeutic target for amyotrophic lateral sclerosis (ALS)
Abati, E., Bresolin, N., Comi, G. P., & Corti, S. P. (2020) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2020.1738390 · Cited by 107
CRISPR engineering in organoids for gene repair and disease modelling
Geurts, M. H., & Clevers, H. (2023) · Nature Reviews Bioengineering · doi:10.1038/s44222-022-00013-5 · Cited by 103
An overview and metanalysis of machine and deep learning-based CRISPR gRNA design tools
Wang, J., Zhang, X., Cheng, L., & Luo, Y. (2019) · RNA Biology · doi:10.1080/15476286.2019.1669406 · Cited by 106
Self-citation
Delivery technologies for T cell gene editing: Applications in cancer immunotherapy
Atsavapranee, E., Billingsley, M. M., & Mitchell, M. J. (2021) · EBioMedicine · doi:10.1016/j.ebiom.2021.103354 · Cited by 104
Genome Editing Reveals Glioblastoma Addiction to MicroRNA-10b
Fatimy, R. E., Subramanian, S., Uhlmann, E. J., & Krichevsky, A. M. (2017) · Molecular Therapy · doi:10.1016/j.ymthe.2016.11.004 · Cited by 102
Functional Genomics via CRISPR–Cas
Ford, K. M., McDonald, D., & Mali, P. (2018) · Journal of Molecular Biology · doi:10.1016/j.jmb.2018.06.034 · Cited by 98
Toward an optimized process for clinical manufacturing of CAR-treg cell therapy
Fritsche, E., Volk, H.-D., Reinke, P., & Abou-El-Enein, M. (2020) · Trends in Biotechnology · doi:10.1016/j.tibtech.2019.12.009 · Cited by 97
CRISPR/Cas9-mediated efficient targeted mutagenesis has the potential to accelerate the domestication of Coffea canephora
Breitler, J., Déchamp, E., Campa, C., Rodrigues, L. A. Z., Guyot, R., Marraccini, P., & Etienne, H. (2018) · Plant Cell Tissue and Organ Culture (PCTOC) · doi:10.1007/s11240-018-1429-2 · Cited by 100
Human stem cell models of neurodegeneration: From basic science of amyotrophic lateral sclerosis to clinical translation
Giacomelli, E., Vahsen, B. F., Calder, E. L., Xu, Y., Scaber, J., Gray, E., Dafinca, R., Talbot, K., & Studer, L. (2022) · Cell stem cell · doi:10.1016/j.stem.2021.12.008 · Cited by 100
Targeting miRNA by CRISPR/Cas in cancer: advantages and challenges
Hussen, B. M., Rasul, M. F., Abdullah, S. R., Hidayat, H. J., Faraj, G. S. H., Ali, F. A., Salihi, A. B., Baniahmad, A., Ghafouri‐Fard, S., Rahman, M., et al. (2023) · Military Medical Research · doi:10.1186/s40779-023-00468-6 · Cited by 106
In situ repurposing of dendritic cells with CRISPR/Cas9-based nanomedicine to induce transplant tolerance
Zhang, Y., Shen, S., Zhao, G., Xu, C., Zhang, H., Luo, Y., Cao, Z., Shi, J. Y., Zhao, Z., Lian, Z., et al. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.119302 · Cited by 96
Optimizing CRISPR/Cas9 for the Diatom Phaeodactylum tricornutum
Stukenberg, D., Zauner, S., Dell’Aquila, G., & Maier, U. G. (2018) · Frontiers in Plant Science · doi:10.3389/fpls.2018.00740 · Cited by 95
A ‘suicide’ CRISPR-Cas9 system to promote gene deletion and restoration by electroporation in Cryptococcus neoformans
Wang, Y., Wei, D., Zhu, X., Pan, J., Zhang, P., Huo, L., & Zhu, X. (2016) · Scientific Reports · doi:10.1038/srep31145 · Cited by 95
Highly efficient DNA-free gene disruption in the agricultural pest Ceratitis capitata by CRISPR-Cas9 ribonucleoprotein complexes
Meccariello, A., Monti, S. M., Romanelli, A., Colonna, R., Primo, P., Inghilterra, M. G., Corsano, G. D., Ramaglia, A., Iazzetti, G., Chiarore, A., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-10347-5 · Cited by 93
CRISPR/Cas9-Mediated Homology-Directed Genome Editing in Pichia pastoris
Gassler, T., Heistinger, L., Mattanovich, D., Gasser, B., & Prielhofer, R. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9024-5_9 · Cited by 92
Advances in CRISPR/Cas9
Zhu, Y. (2022) · BioMed Research International · doi:10.1155/2022/9978571 · Cited by 103
Genetic engineering to enhance microalgal-based produced water treatment with emphasis on CRISPR/Cas9: A review
Hassanien, A., Saadaoui, I., Schipper, K., Al-Marri, S., Dalgamouni, T., Aouida, M., Saeed, S., & Jabri, H. M. S. J. A. (2023) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.1104914 · Cited by 94
Recent advancements in reducing the off-target effect of CRISPR/Cas9 genome editing
Asmamaw Mengstie, M., Teshome Azezew, M., Asmamaw Dejenie, T., Teshome, A. A., Tadele Admasu, F., Behaile Teklemariam, A., Tilahun Mulu, A., Mekonnen Agidew, M., Adugna, D. G., Geremew, H., et al. (2024) · Biologics: Targets and Therapy · doi:10.2147/btt.s429411 · Cited by 91
Development of a Cre-loxP-based genetic system in Aspergillus niger ATCC1015 and its application to construction of efficient organic acid-producing cell factories
Xu, Y., Shan, L., Zhou, Y., Xie, Z., Ball, A. S., Cao, W., & Liu, H. (2019) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-019-10054-3 · Cited by 91
Improvements in Gene Editing Technology Boost Its Applications in Livestock
Périssé, I. V., Fan, Z., Singina, G. N., White, K. L., & Polejaeva, I. A. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2020.614688 · Cited by 88
Editing streptomycete genomes in the CRISPR/Cas9 age
Alberti, F., & Corre, C. (2019) · Natural Product Reports · doi:10.1039/c8np00081f · Cited by 93
Orthologous CRISPR/Cas9 systems for specific and efficient degradation of covalently closed circular DNA of hepatitis B virus
Kostyushev, D. S., Brezgin, S., Kostyusheva, A., Zarifyan, D., Goptar, I. A., & Chulanov, V. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03021-8 · Cited by 90
CRISPR/Cas9 revitalizes adoptive T-cell therapy for cancer immunotherapy
Ghaffari, S., Khalili, N., & Rezaei, N. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-02076-5 · Cited by 91
Biomaterials-mediated CRISPR/Cas9 delivery: recent challenges and opportunities in gene therapy
Dubey, A. K., & Mostafavi, E. (2023) · Frontiers in Chemistry · doi:10.3389/fchem.2023.1259435 · Cited by 93
Transgene-free Genome Editing in Plants
Gu, X., Liu, L., & Zhang, H. (2021) · Frontiers in Genome Editing · doi:10.3389/fgeed.2021.805317 · Cited by 88
Recent advances in the delivery and applications of nonviral CRISPR/Cas9 gene editing
Sinclair, F., Begum, A. A., Dai, C. C., Tóth, I., & Moyle, P. M. (2023) · Drug Delivery and Translational Research · doi:10.1007/s13346-023-01320-z · Cited by 91

Authors: Zhang, X.-H., Tee, L. Y., Wang, X.-G., Huang, Q.-S., & Yang, S.-H.
Affiliations: McGovern Institute for Brain Research (US)
ORCID: Tee, Louis Y
Venue: Molecular Therapy - Nucleic Acids
Publisher: Elsevier BV
Published: 2015
Volume: 4
Pages: e264
ISSN: 2162-2531 (ISSN-L)
DOI: 10.1038/mtna.2015.37
PMC: PMC4877446
OpenAlex: W2173737475
Cited by: 1,273
References: 82
Citations by year: 2026: 67 · 2025: 145 · 2024: 166 · 2023: 151 · 2022: 164 · 2021: 198 · 2020: 132 · 2019: 109 · 2018: 80 · 2017: 35 · 2016: 25 · 2015: 1
FWCI: 4.55
Type: journal article
Language: en
Open access: gold
doi.org
Licence: cc-by-nc-sa
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
creativecommons.org/licenses/by-nc-sa/4.0/ (vor, 645 d)
Locations: Molecular Therapy — Nucleic Acids (publishedVersion, cc-by-nc-sa)
Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
PubMed Central (publishedVersion, cc-by-nc-sa)
PubMed (publishedVersion)
DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
Keywords: CRISPR/Cas9, off-target effects, genome editing, RNA-guided endonuclease, genome editing specificity, therapeutic genome editing

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Off-target Effects in CRISPR/Cas9-mediated Genome Engineering

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks